Leucine Rich Repeat Kinase drugs in development, 2024 - Pharmaceutical Technology

Retrieved on: 2024-10-02 03:27:48

Tags for this article:

LRRK2

Parkinson's disease

Targeted therapy

Tyrosine kinase receptors

Click the tags to see associated articles and topics

Leucine Rich Repeat Kinase drugs in development, 2024 - Pharmaceutical Technology. View article details on hiswai:

Summary

The article discusses Leucine Rich Repeat Kinase pipeline drugs, focusing on Parkinson's disease among other indications. Business Intelligence is highlighted as crucial for understanding market dynamics and making informed decisions about drug development and therapeutic targets.

Article found on: www.pharmaceutical-technology.com

View Original Article